WebbPrior to this, he was CEO and co-founder of Therachon AG, which was acquired by Pfizer, Inc. in 2024 for $810 million. Luca previously worked at Roche for 12 years, where he advanced over 20 molecules into the clinic, catalyzed the creation of Synosia and Clementia, two companies built from Roche asset spin-offs, and led multiple in-licensing … WebbTherachon AG is a Biotechnology, Drug Discovery, and Science and Engineering company located in Basel, Basel City with $12.80 Million in revenue and 6 employees. Find top …

Safe and persistent growth-promoting effects of vosoritide in ... - Nature

Webb8 jan. 2024 · Januar 2024 /PRNewswire/ -- Therachon AG („Therachon"), ein Biotechnologieunternehmen mit klinischen Entwicklungsprodukten, das seinen … Webb20 jan. 2024 · Molecular Partners AG is a clinical-stage biotech company that is developing a new class of therapies known as DARPin® therapeutics. The company continues to attract talented individuals who share the passion to develop breakthrough medicines for serious diseases. great clips wakefield commons raleigh nc

EU grants Therachon Orphan Drug Designation

WebbDate range: 1 April 2024 - 31 March 2024 No articles found. Therachon AG did not contribute to any primary research papers from Nature Index journals in the current 12 … WebbTherachon is a global biotechnology company, focused on developing treatments for rare, genetic diseases that currently have no available treatments. We are committed to the … WebbFor instance, in July 2024, Pfizer Inc., a U.S.-based multinational pharmaceutical and biotechnology corporation, announced completion of its acquisition of Therachon … great clips wait times